J. B. Chemicals & Pharmaceuticals Limited
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	3/31/2021	3/31/2022	3/31/2024	3/31/2026	3/31/2027	3/31/2028
Revenue % change YoY	₹20.05B N/A	₹24.24B 20.85%	₹34.47B 42.21%	Avg: ₹45.72B Low: ₹45.72B High: ₹45.72B avg. 32.63%	Avg: ₹51.15B Low: ₹51.15B High: ₹51.15B avg. 11.86%	Avg: ₹57.21B Low: ₹57.21B High: ₹57.21B avg. 11.84%
Net Income % change YoY	₹4.47B N/A	₹3.85B -13.97%	₹5.52B 43.40%	Avg: ₹8.43B Low: ₹8.43B High: ₹8.43B avg. 52.66%	Avg: ₹9.66B Low: ₹9.66B High: ₹9.66B avg. 14.55%	Avg: ₹11.80B Low: ₹11.80B High: ₹11.80B avg. 22.19%
EBITDA % change YoY	₹6.72B N/A	₹5.44B -18.94%	₹9.33B 71.31%	Avg: ₹17.40B Low: ₹17.40B High: ₹17.40B avg. 86.47%	Avg: ₹19.47B Low: ₹19.47B High: ₹19.47B avg. 11.86%	Avg: ₹21.77B Low: ₹21.77B High: ₹21.77B avg. 11.84%
EPS % change YoY	$28.98 N/A	$24.93 -13.97%	$35.66 43.04%	Avg: $53.44 Low: $53.44 High: $53.44 avg. 49.84%	Avg: $61.21 Low: $61.21 High: $61.21 avg. 14.55%	Avg: $74.8 Low: $74.8 High: $74.8 avg. 22.19%
Operating Expenses % change YoY	₹8.00B N/A	₹10.86B 35.61%	₹14.79B 36.17%	Avg: ₹7.17B Low: ₹7.17B High: ₹7.17B avg. -51.47%	Avg: ₹8.02B Low: ₹8.02B High: ₹8.02B avg. 11.86%	Avg: ₹8.97B Low: ₹8.97B High: ₹8.97B avg. 11.84%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 29.80% in 2026-2028.

We have gathered data from N/A analysts. Their low estimate is 8.43B, average is 8.43B and high is 8.43B.

Wall Street analysts forecast annual average revenue growth of 18.78% in 2026-2028.

We have gathered data from N/A analysts. Their low revenue estimate is ₹45.72B, average is ₹45.72B and high is ₹45.72B.

Wall Street analysts forecast annual average earnings growth of 28.86% in 2026-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is $53.44, average is $53.44 and high is ₹53.43.